IJCRR - 5(12), June, 2013
EVALUATION OF DIABETIC PERIPHERAL NEUROPATHY IN KNOWN CASES OF TYPE 2 DIABETES IN URBAN AND RURAL POPULATION
Author: Lakshmana Kumar N., Mallikarjuna Rao K.V.N., Srinivas Ch, Kishore K., Kiran Deedi M. , Lakshmana Rao N.
Background: Diabetic Peripheral Neuropathy (DPN) is one of the microvascular complications of diabetes, and is responsible for most of the amputations in diabetes. Measurement of Vibration Perception Threshold (VPT) is useful in assessment of peripheral neuropathy. The aim of the study is to study the role and correlation of age, duration of diabetes, fasting plasma glucose, HbA1C, and microalbumin:creatinine ratio with diabetic peripheral neuropathy in known cases of type 2 diabetes mellitus in urban and rural population of Rajahmundry, Andhra Pradesh, India. Methods: Study was done on two groups comprising of 30 cases with normal VPT and 30 cases with abnormal VPT in type 2 diabetes. Age, duration of diabetes, body mass index, fasting plasma glucose, HbA1C, and microalbumin:creatinine ratio were recorded and analyzed. Results: Significant difference in age, duration of diabetes, fasting plasma glucose, HbA1C, and microalbumin:creatinine ratio is observed between groups (P < 0.05). There is significant correlation of age, duration of diabetes, fasting plasma glucose, HbA1C, and microalbumin:creatinine ratio with VPT (P < 0.05) in all cases. Among the correlating parameters multiple regression analysis revealed that age and HbA1C are good predictors of VPT (P < 0.05). Conclusion: Age, duration of diabetes, fasting plasma glucose, HbA1C, and microalbuminuria were associated with DPN in urban and rural population. However age and HbA1C are strong predictors of changes in VPT. There is need to study the prevalence of and other risk factors associated with DPN with a larger sample size in this area.
Keywords: Diabetes, Peripheral neuropathy, Vibration perception threshold, Risk factors.
Lakshmana Kumar N., Mallikarjuna Rao K.V.N., Srinivas Ch, Kishore K., Kiran Deedi M. , Lakshmana Rao N.. EVALUATION OF DIABETIC PERIPHERAL NEUROPATHY IN KNOWN CASES OF TYPE 2 DIABETES IN URBAN AND RURAL POPULATION International Journal of Current Research and Review. 5(12), June, 51-56
1. Ronald C.W. Ma, Petr C.Y. Tong. Epidemiology of Type 2 Diabetes. In: Richard I.G. Holt, Clive S. Cockram, Allan Flyvbjerg, Barry J. Goldstein, editors. Text book of Diabetes. 4th ed. 20 West Sussex (UK): Wiley –Blackwell; pp.45-46.
2. Shashank R Joshi, AK Das, VJ Vijay, V Mohan. Challenges in Diabetes Care in India: Sheer Numbers, Lack of Awareness and Inadequate Control. J Assoc Physicians India 2008;56: 443-50.
3. Shaw JE, Zimmet PZ, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of Diabetic Neuropathy. Stuttgart/Newyork: Thieme, 2003;64-82.
4. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-962.
5. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care 1989;12:24-31.
6. Consensus Development Conference on Standardised Measures in Diabetic Neuropathy. Proceedings of a consensus development conference on standardised measures in diabetic neuropathy. Diabetes Care 1992;15(3):1080-1107.
7. Abbott CA, Vileikyte L, Willimason S, Carrington AL, Boulton AJM. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998;21:1071- 1075.
8. Coppini DV, Bowtell PA, Weng C, Young MJ, Sonksen PH. Showing neuropathy is related to increased mortality in diabetic patients: a survival analysis using an accelerated failu re time model. J Clin Epidemiol 2000.;53:519-523.
9. Hari KVS Kumar, SK Kota, A Basile, KD Modi. Profile of Microvascular Disease in Type 2 Diabetes in a tertiary Health Care Hospital in India. Ann Med Health Sci Res 2012;2(2):103-108.
10. Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian J Med Sci 2010;64:51-57.
11. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors of Diabetic neuropathy in an Urban south Indian population: The Chennai Urban Rural Epidemilogy Study (CURES-55). Diabet Med 2008;25:407-12.
12. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population based cohort: The Rochestor Diabetic Neuropathy Study. Neurology 1993;43:817-824.
13. Young MJ, Boulton AJM, Macleod AF, Willims DRR, Sonksen PH. A multicentre study of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36(2):150-154.
14. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with NIDDM. N Engl J Med 1995;333(2):89-94.
15. Ferdinando Giacco, Michael Brownlee. Pathogenesis of Microvascular Complications. In: Richard I.G. Holt, Clive S. Cockram, Allan Flyvbjerg, Barry J. Goldstein, editors. Text book of Diabetes. 4th ed. 20 West Sussex (UK): Wiley –Blackwell; pp.555-574.
16. Lakshmana Kumar N, Mallikarjuna Rao KVN, Kishore K, Priyadarsini DVS, Kiran Deedi M, Laxman Rao N. Awareness of Diabetes and its relation to prevalence of microalbuminuria in known cases of Type 2 Diabetes. Indian Journal of Public Health Research and Development. In press 2013.
17. Al-Kateb H, Boright AP, Mirea L, Xie X, Sutradhar R, Mowjoodi A, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Multiple super oxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy:the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 2008;57:218-228.